Image For Activity Cover
2019 HFSA Comprehensive HF Review
General Meeting Information
The 2019 Comprehensive Heart Failure Review Course builds upon HFSA’s successful 2017 Review and 2018 Board Review Courses by incorporating results of new research studies, increasing focus on practical management recommendations, addressing issues encountered in practice, adding case studies, and providing breakout session in areas of special interest.
Intended Audience
Cardiologists, internists, nurses, clinical pharmacists and other health professionals with a special interest in heart failure.
Learning Objectives & Competencies Addressed
At the conclusion of this educational activity, will be able to:
  1. Describe the epidemiology of heart failure and implement strategies for the prevention of heart failure.
  2. Describe the pathophysiology of heart failure, including normal physiology and compensatory and maladaptive mechanisms.
  3. Assess and track the patient with acute or advanced heart failure, using non-invasive and invasive tests and biomarkers.
  4. Implement guideline-based therapy for patients with chronic heart failure, including pharmacologic agents and non-pharmacologic options, such as diet and exercise; and implantable devices.
  5. Apply appropriate care strategies for patients with pulmonary hypertension, RV failure, heart failure with preserved ejection fraction, cardiorenal syndrome, peripartum and infiltrative myopathies.
  6. Manage comorbidities in patients with chronic heart failure, including sleep disordered breathing, anemia, and depression.
  7. Implement strategies for effective disease management of the patient with advanced heart failure, including palliative care and transition to outpatient care.
  8. Describe characteristics of optimal candidates for cardiac transplantation or mechanical circulatory support.
  9. Apply strategies for atrial and ventricular arrhythmia management.
  10. Practice effectively in the context of health
Competencies Addressed
  • Patient care
  • Medical knowledge
  • Interpersonal and communication skills
  • Professionalism
  • Systems‐based
ABIM-specific compentency areas in advaned heart failyre and transplant cardiology:
  • Epidemiology and risk factors
  • Pathophysiology of heart failure
  • Hemodynamics and hemodynamic monitoring
  • Heart failure and normal ejection fraction
  • Heart failure with renal dysfunction/cardiorenal syndrome
  • Diagnostic tests and procedures
  • Acute decompensation of chronic heart failure
  • Heart failure comorbidities
  • Cardiomyopathies
  • Pharmacotherapy
  • Implantable devices
  • Heart transplant
  • Mechanical circulatory
Co-Chairs & Planning Committee
Co-Chairs
Sean P. Pinney, MD
Director, Advanced Heart Failure and Transplantation Program,
The Mount Sinai Hospital
New York, NY

Marie Galvao, MSN, ANP‐BC, CHFN
Lead Heart Failure Nurse Practitioner
Center for Advanced Cardiac Therapy
Montefiore Medical Center
Bronx, NY

Robert Page II, PharmD, MSPH, BCPS (AQ-cards), FHFSA, FAHA Co-Chair
Professor of Clinical Pharmacy
Clinical Specialist, Division of Cardiology
Section of Advanced Heart Failure/ Heart Transplant
University of Colorado, Skaggs School of Pharmacy
Denver, CO

Planning Committee Member
Christina Redmond, MSN, ARNP
Nurse Practitioner
University of Washington Physicians
Seattle, Washington

Faculty
Luis H. Arroyo, MD
Director, Heart Failure and Transplant Fellowship
Tampa General Hospital & Medical Group
Tampa, FL

Theodore Berei, PharmD, MBA, BCPS, BCCP
Clinical Pharmacist
University of Wisconsin Hospital and Clinics
Madison, WI

Maria Rosa Costanzo, MD
Medical Director, Advocate Medical Group-Midwest Heart Specialists
Heart Failure and Pulmonary Arterial Hypertension Programs
Medical Director, Edward Hospital Center for Advanced Heart Failure
Naperville, IL

Stephen Clum, PhD, MD
Assistant Professor, College of Medicine Internal Medicine
Division of Pulmonary, Critical Care and Sleep Medicine
Tampa, FL

James C. Fang, MD, HFSA
Professor of Medicine
Chief, Division of Cardiovascular Medicine
Executive Director, Cardiovascular Service Line
University of Utah
Salt Lake City, UT

Kathleen D. Faulkenberg, PharmD, BCPS
Clinical Pharmacist
Advanced Heart Failure and Heart Transplant
Cleveland Clinic
Cleveland, Ohio

Mahazrin B. Ginwalla, MD, MS, FACC
Assistant Professor of Medicine
Medical Director of Mechanical Circulatory Support
Division of Cardiovascular Medicine
University Hospitals of Cleveland
Cleveland, OH

Susan M. Joseph, MD
Advanced Heart Failure Clinic
Baylor Scott & White Heart and Vascular Hospital
Dallas, TX

Manreet Kanwar, MD
Allegheny Health Network
Associate Professor of Medicine at Temple University School of Medicine,
Pittsburgh, PA

Lisa LeMond, MD
Advanced Heart Failure and Transplant Cardiology Specialist
Mayo Clinic
Scottsdale, AZ

Robert J. Mentz, MD, FHFSA
Associate Professor of Medicine
Associate Professor, Population Health Sciences
Duke University

Sumeet Mitter, MD, MSCE
Assistant Professor of Medicine
Advanced Heart Failure and Transplant
The Mount Sinai Hospital
New York, NY

Linda Ordway, RN, MS, ACNP, CHFN, NP
NP, Clinical Care Manager, Cardiomyopathy Center
Cardiac Transplant and VAD Program
Tufts Medical Center
Boston, MA

Sara Paul, DNP, FNP, FHFSA
Director, Heart Function Clinic
Catawba Valley Cardiology
Hickory, NC

Lisa D. Rathman, MSN, CRNP, CCRN
Lead Heart Failure Nurse Practitioner
Lancaster General Heart Failure Clinic
The Heart Group of Lancaster General Health Group/
Lancaster General Hospital CHF Program
Lancaster, PA

Nirav Raval, MD
Medical Director of Thoracic Transplant Heart, VAD Program
Florida Hospital Transplant Institute
Orlando, FL
Jonathan D. Rich, MD, FHFSA
Associate Professor of Medicine – Cardiology
Northwestern University Feinberg School of Medicine
Chicago, IL

Debbie Rinde-Hoffman, MD, FHFSA
Tampa General Medical Group
Tampa, FL

Nir Uriel, MD, MSc
Louis Block Professor of Medicine
Director, Heart Failure, Transplant and Mechanical Circulatory Support
University of Chicago
Chicago, IL

Usman Siddiqui, MD
Florida Cardiology
Osceola Regional Medical Center
Florida Cardiology, PA
Orlando, FL

Justin M. Vader, MD
Assistant Professor of Medicine
Co-Director, Advanced Heart Failure and Cardiac Transplantation Fellowship
Washington University
St. Louis, MO
Course Details & Faculty Listing
SESSION 1 - Acute and Chronic HF
Moderator: Sean P. Pinney, MD, FHFSA
  • Models and Mechanisms of HFrEF and HFpEF - James C. Fang, MD, FHFSA
  • HF Pathway - Translating Guidelines Into Clinical Practice  - Robert J. Mentz, MD, FHFSA
  • Transcatheter Mitral Valve Repair and Replacement  - Nir Uriel, MD, MSc
  • Diabetes & Heart Failure - Robert J. Mentz, MD, FHFSA
  • Emerging Therapies: New Indications and Drugs in the Pipeline  - Theodore Berei, PharmD, MBA, BCPS, BCCP
  • HFpEF: Therapeutic Options - Sumeet Mitter, MD, MSCE
  • Acute HF:  Natural History & Patient Assessment - James C. Fang, MD, FHFSA
  • Inotropes - What’s New? - Mahazrin B. Ginwalla, MD, MS
  • Acute HF: Congestion, Cardiorenal and Diuretic Resistance - Maria Rosa Costanzo, MD
  • Case Based Discussion - HF Across Lifespan (Acute and Chronic) - Moderator: Marie Galvao, MSN, ANP-BC, CHFN
    • Panel Discussants: Robert J. Mentz, MD, FHFSA ; Lisa D. Rathman, MSN, CRNP, CCRN; Theodore Berei, PharmD, MBA, BCPS, BCCP
SESSION 2 - Pulmonary Hypertension and RV Failure
Moderator: Robert Page II, PharmD, MSPH, BCPS, FHFSA
  • Pulmonary Hypertension I:  Diagnosis and Management - Jonathan D. Rich, MD, FHFSA
  • Pulmonary Hypertension II:  Pharmacotherapy - Jonathan D. Rich, MD, FHFSA
  • Who II PH and Right Failure  - Manreet Kanwar, MD
  • Case Based Discussion -  Moderator: Sean P. Pinney, MD;
    • Panel Discussants: Jonathan D. Rich, MD, FHFSA; Linda Ordway, RN, MS, ACNP, CHFN; Robert Page II, PharmD, MSPH, BCPS, FHFSA
BREAKOUT SESSION I
  • Assessment of Patient with New Onset HF
    Marie Galveo, MSN, ANP-BC, CHFN; Robert Page II, PharmD, MSPH, BCPS, FHFSA; Maria Rosa Costanzo, MD
  • Cardiopulmonary Exercise Stress Testing (CPET)
    Stephen Clum, PhD, MD; Mahazrin B. Ginwalla, MD, MS
  • How to Set up a HF Clinic
    Sumeet Mitter, MD, MSCE; Sara Paul, DNP, FNP, FHFSA; Kathleen D. Faulkenberg, PharmD 
SESSION 3 - Advances in Patient Monitoring 
Moderator: Marie Galvao, MSN, ANP‐BC, CHFN
  • Biomarker 2019 Update:  What’s Hot, What’s Not? - Mahazrin B. Ginwalla, MD, MS
  • Invasive and Non-Invasive Hemodynamic Devices - Manreet Kanwar, MD 
  • Remote Monitoring: Smart Phones to Telehealth - Lisa D. Rathman, MSN, CRNP, CCRN
  • Sleep Disordered Breathing  - Sara Paul, DNP, FNP, FHFSA
  • Q&A
SESSION 4 - Cardiogenic Shock / MCS / Transplant
  • Cardiogenic Shock: Pathophysiology, Hemodynamics and Outcomes - Debbie Rinde-Hoffman, MD, FHFSA
  • Percutaneous Devices and ECMO - Susan M. Joseph, MD
  • Cardiac Amyloidosis - Sumeet Mitter, MD, MSCE 
SESSION 5  - SPECIAL SESSION - Patient Preferences 
Moderator: Sean P. Pinney, MD
  • Patient Preferences vs Provider Perception - Luis H . Arroyo, MD; Linda Ordway, RN, MS, ACNP; Robert Page II, PharmD, MSPH, BCPS, FHFSA
  • Patient Panel
SESSION 6  - HF and Arrhythmia Management  
Moderator: Sean P. Pinney, MD
  • Impact of AFIB on HF - Sean P. Pinney, MD
  • EP Device Therapy of HF: CRT, HIS  Bundle Pacing and CCM - Usman Siddiqui, MD
  • Arrhythmia Management: Antiarrhythmic Drugs and VT Ablation  - Usman Siddiqui, MD
  • Prevention of Sudden Cardiac Death, Wearables and Implantables  - Luis Arroyo, MD 
BREAKOUT SESSIONS II
  • How to Setup a Remote Monitoring Program - Lisa D. Rathman, MSN, CRNP, CCRN; Robert Page II, PharmD, MSPH, BCPS, FHFSA
  • Having the Discussion - How to Make the Conversation Easier - Maria Rosa Costanzo, MD; Sara Paul  DNP, FNP, FHFSA
  • Clinical Conundrums - Case Review - Sean P. Pinney, MD; Marie Galvao, MSN, ANP‐BC, CHFN; Kathleen D. Faulkenberg, PharmD
SESSION  7 - Special Populations 
Moderator: Marie Galvao, MSN, ANP‐BC, CHFN lations 
  • Defining Advanced HF - Sean P. Pinney, MD
  • Inflammatory Cardiomyopathies, Myocarditis and Sarcoidosis - Nirav Raval, MD
  • Metabolic Challenges: Obesity and Anemia - Justin Vader, MD
  • HF and Pregnancy - Lisa LeMond, MD
  • Hypertrophic Cardiomyopathies and Screening for Sudden Cardiac Death - Nirav Rival, MD
SESSION 8 - Transitional & Palliative Care
Moderator: Robert Page II, PharmD, MSPH, BCPS, FHFSA
  • Cardio-Oncology - Justin Vader, MD
  • Transitional Care Planning & Strategies for Keeping People Out of the Hospital - Sara Paul, DNP, FNP, FHFSA
  • Pallative Care and Hospice - Lisa LeMond, MD
  • Q&A
Accreditation Statement

PHYSICIANS
The Heart Failure Society of America is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The Heart Failure Society of America designates this live activity for a maximum of 18.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.  

Successful completion of this CME activity, which includes participation in the evaluation component and post-test with 75% passing score, enables the participant to earn up to 18.50 MOC points in the Maintenance of Certification (MOC) program. 

NURSES
This continuing nursing education activity was approved by the Ohio Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. (OBN-001-91)
This activity is approved for 18.50 contact hours.
Approval through 10/23/2021; ONA #22787

CRITERIA FOR SUCCESSFUL COMPLETION & CREDIT CERTIFICATES
Successful completion of this continuing education activity includes participation in the evaluation post course evaluation and post-course test with a passing score of 75%.

Faculty and Accreditor Disclosures

The following accreditors with ability to control content for this activity have no conflict of interest:
Luis H. Arroyo, MD
Theodore Berei, PharmD, MBA, BCPS, BCCP
Stephen Clum, PhD, MD
Kathleen D. Faulkenberg, PharmD
Manreet Kanwar, MD
Joseph Lawrie (Patient)
Lisa LeMond, MD
Sanwarren Nix (Patient)
Linda Ordway, RN, MS, ACNP, CHFN
Robert Page II, PharmD, MSPH, BCPS, FHFSA - Co-Chair; (Planning Committee & Presenter)
Nirav Raval, MD
Christina Redmond, MSN, ARNP (Planning Committee)
Jonathan Rich, MD, FHFSA
Debbie Rinde-Hoffman, MD, FHFSA
Justin Vader, MD
William Vanwagner (Patient)

HFSA Staff Planners
Jaime Abreu, MBA
Shauna Brown
Cynthia Miranda

The following accreditors with ability to control content for this activity have listed the below disclosures:
Maria Rosa Costanzo, MD
Consultant-Advisory Board: CHF-Solutions; Magenta Medical; Sequana; Axon Technologies

James C. Fang, MD, FHFSA
Consultant-Advisory Board: Novartis; Amgen; Capricor; Johnson & Johnson; American Heart Association; NIH; PVOMICS/CTSN

Marie Galvao, MSN, ANP‐BC, CHFN  - Co-Chair
(Planning Committee & Presenter)
Speaker Honoraria: Boston Scientific
Consultant-Advisory Board: Boston Scientific

Mahazarin Ginwalla, MD, MS
Research Grant: Amgen
Speaker-Honoraria: Zoll
Consultant-Advisory Board: Xact Labs

Susan M. Joseph, MD
Speaker-Honoraria: Abbott
Consultant-Advisory Board: Medtronic

Robert J. Mentz, MD, FHFSA
Research Grant: Amgen; AstraZeneca; Bayer; GlaxoSmithKline; American Regent; Medtronic; Merck; Novartis; Sanofi
Speaker-Honoraria: Amgen; AstraZeneca; Bayer; Innolife; Medtronic; Merck; Novartis; Sanofi; Abbott; Boston Scientific; Janssen; Vifor; Boehringer Ingelheim
Consultant-Advisory Board: Amgen; AstraZeneca; Innolife; Metronic; Merck; Novartis; Sanogi; Abbott; Vifor; Boehringer Ingelheim

Sumeet Mitter, MD, MSCE
Speaker-Honoraria: Abbott; Cowen & Co.; American College of Cardiology
Consultant-Advisory Board: AstraZeneca; Pfizer

Sara Paul, DNP, FNP, FHFSA
Consultant-Advisory Board: Abbott

Sean P. Pinney, MD - Co-Chair
(Planning Committee & Presenter)
Speaker-Honoraria: CareDx
Consultant-Advisory Board: Abbot, Inc.; CareDx; Medtronic, Inc.

Lisa D. Rathman, MSN, CRNP, CCRN
Research Grant: Abbott
Speaker-Honoraria: Abbott, Boston Scientific
Consultant-Advisory Board: Abbott, Boston Scientific, Amgen, Alnylam, Pfizer, Boehringer Ingelheim, SC Pharma

Usman Siddiqui, MD
Consultant-Advisory Board: Biosense Webster; Medtronic; Impulse Dynamics; Stereotaxis

Nir Uriel, MD, MSc
Research Grant: Abbott, Medtronic, Novartis
Consultant-Advisory Board: Leviticus, Cormetric

Summary
Availability: On-Demand
Cost: Member: $799.00
Non-Member: $899.00
Credit Offered: 18.5 CEU Credits
18.5 CME Credits
18.5 MOC Points
Contains: 18 Courses
Powered by Oasis.